Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection — LIZ-BONE  

Hip Prosthetic Joint Infection Clinical Trial

Official title: Prospective,Randomized,Open Label,European Multicenter Study of the Efficacy of the Linezolid-rifampin Combination Versus Standard of Care in the Treatment of Gram-positive.

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of oral linezolid-rifampin combination therapy (over 4 or 6 weeks) versus the standard of care in the treatment of Gram-positive prosthetic hip joint infection with a one-stage surgical treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Arthritis, Infectious
• Hip Prosthetic Joint Infection

• NCT number: NCT01757236
• Study type: Interventional
• Source: University Hospital, Tours
• Contact: Louis BERNARD
• Phone: + 33 (0) 2 47 47 97 74
• Email: l.bernard@chu-tours.fr
• Status: Recruiting
• Phase: Phase 2
• Start date: October 2012
• Completion date: April 2016